glp-1 and parkinson's Are we measuring the wrong primary outcome for drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Some epidemiologic studies have suggested
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28






















:max_bytes(150000):strip_icc()/VWH-GettyImages-1363761716-bdb33fc2d4ab425088b9366044ff18ca.jpg)





